AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 278: H1473-H1479, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez-Patron, C.
Right arrow Articles by Davidge, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Patron, C.
Right arrow Articles by Davidge, S. T.
Vol. 278, Issue 5, H1473-H1479, May 2000

Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries

Carlos Fernandez-Patron1, Marek W. Radomski2, and Sandra T. Davidge1

1 Perinatal Research Centre, Departments of Obstetrics/Gynaecology and Physiology, University of Alberta, Edmonton, Alberta T6G 2S2; and 2 Department of Pharmacology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

The vasodilator effects of thrombin depend on activation of proteinase-activated receptor (PAR)-1 and the subsequent release of endothelin (ET)-1, which stimulates the generation of nitric oxide and PGs. We recently showed that thrombin released matrix metalloproteinase-2 (MMP-2) from rat arteries. We have now studied the significance of this release for the vasodilator effects of thrombin. Thrombin (>= 100 pmol), but not a PAR-1-activating peptide (TFLLR-NH2), produced a long-lasting (>10 min) vasorelaxation of rat mesenteric arteries, as detected by a microperfusion bioassay. Thrombin induced a simultaneous release of vascular MMP-2 into arterial perfusates, as revealed by zymography. Interestingly, the vasodilator effects of thrombin were inhibited by a tissue inhibitor of MMP-2 (TIMP-2, 10 pmol). Moreover, infusion of exogenous MMP-2 (5 pmol) resulted in vasorelaxation. These vasodilatory effects of thrombin and MMP-2 were significantly (P < 0.05) inhibited by endothelium denudation and by PD-142893 (2 nmol), an antagonist of ET receptors. Furthermore, both thrombin and MMP-2 constricted endothelium-denuded arteries. These results show that the vasodilator effects of thrombin may depend, in part, on a release of vascular MMP-2 and downstream activation of ETs. Thus MMP-2-dependent signaling may complement the PAR-1-dependent pathway of vasodilator action of thrombin.

endothelin; vascular; injury; nitric oxide; prostaglandins


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. W. Watts, C. Rondelli, K. Thakali, X. Li, B. Uhal, M. H. Pervaiz, R. E. Watson, and G. D. Fink
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2438 - H2448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Z. He, A. Quan, Y. Xu, H. Teoh, G. Wang, J. E. Fish, B. M. Steer, S. Itohara, P. A. Marsden, S. T. Davidge, et al.
Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H684 - H693.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Jeyabalan, L. J. Kerchner, M. C. Fisher, J. T. McGuane, K. D. Doty, and K. P. Conrad
Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats
J Appl Physiol, June 1, 2006; 100(6): 1955 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K. P. Conrad
Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy
Reproductive Sciences, October 1, 2004; 11(7): 438 - 448.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Kawabata, S. Kubo, Y. Nakaya, T. Ishiki, R. Kuroda, F. Sekiguchi, N. Kawao, and H. Nishikawa
Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery
Cardiovasc Res, March 1, 2004; 61(4): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Kohlstedt, R. P. Brandes, W. Muller-Esterl, R. Busse, and I. Fleming
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells
Circ. Res., January 9, 2004; 94(1): 60 - 67.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Fernandez-Patron, K. G. Stewart, Y. Zhang, E. Koivunen, M. W. Radomski, and S. T. Davidge
Vascular Matrix Metalloproteinase-2-Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction
Circ. Res., October 13, 2000; 87(8): 670 - 676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online